Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 397322-82-6 | MDL No. : | MFCD13193431 |
Formula : | C7H6ClNO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | FVFGTMXRHNSEMC-UHFFFAOYSA-N |
M.W : | 155.58 | Pubchem ID : | 23510442 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 41.24 |
TPSA : | 43.09 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.91 cm/s |
Log Po/w (iLOGP) : | 1.29 |
Log Po/w (XLOGP3) : | 1.88 |
Log Po/w (WLOGP) : | 1.74 |
Log Po/w (MLOGP) : | 1.39 |
Log Po/w (SILICOS-IT) : | 1.9 |
Consensus Log Po/w : | 1.64 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.37 |
Solubility : | 0.668 mg/ml ; 0.0043 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.41 |
Solubility : | 0.61 mg/ml ; 0.00392 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.59 |
Solubility : | 0.402 mg/ml ; 0.00258 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.0 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H317-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
74% | With manganese(IV) oxide In dichloromethane at 20℃; for 20 h; Inert atmosphere | General procedure: To a solution of 1a (1.2 g, 7.61 mmol) in CH2Cl2 (20 mL) was added MnO2 (2.6 g, 30.1 mmol) and stirred at rt under an Ar atmosphere. After 23 h with stirring, the reaction mixture was filtrated and evaporated. The residue was crystallized from AcOEt to give 7a (1.0 g, 85percent) as a yellow needle crystal. |
[ 56762-32-4 ]
1-(2-Amino-3-chlorophenyl)ethanone
Similarity: 0.89
[ 163458-94-4 ]
2-Amino-4,5-dichlorobenzaldehyde
Similarity: 0.87
[ 56762-32-4 ]
1-(2-Amino-3-chlorophenyl)ethanone
Similarity: 0.89
[ 163458-94-4 ]
2-Amino-4,5-dichlorobenzaldehyde
Similarity: 0.87
[ 163458-94-4 ]
2-Amino-4,5-dichlorobenzaldehyde
Similarity: 0.87
[ 62909-66-4 ]
4-Amino-3,5-dichlorobenzaldehyde
Similarity: 0.85
[ 56762-32-4 ]
1-(2-Amino-3-chlorophenyl)ethanone
Similarity: 0.89
[ 163458-94-4 ]
2-Amino-4,5-dichlorobenzaldehyde
Similarity: 0.87